INNOVIVA INC (INVA) Stock Fundamental Analysis
USA - NASDAQ:INVA - US45781M1018 - Common Stock
22.26 USD
+0.01 (+0.04%)
We assign a fundamental rating of 7 out of 10 to INVA. INVA was compared to 192 industry peers in the Pharmaceuticals industry. INVA gets an excellent profitability rating and is at the same time showing great financial health properties. INVA may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, INVA could be worth investigating further for value and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year INVA was profitable.
In the past year INVA had a positive cash flow from operations.
Each year in the past 5 years INVA has been profitable.
In the past 5 years INVA always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 8.91%, INVA belongs to the best of the industry, outperforming 91.15% of the companies in the same industry.
INVA's Return On Equity of 12.61% is amongst the best of the industry. INVA outperforms 87.50% of its industry peers.
INVA's Return On Invested Capital of 9.43% is amongst the best of the industry. INVA outperforms 88.02% of its industry peers.
The Average Return On Invested Capital over the past 3 years for INVA is below the industry average of 13.75%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.91% | ||
| ROE | 12.61% | ||
| ROIC | 9.43% |
ROA(3y)11.21%
ROA(5y)16.95%
ROE(3y)22.61%
ROE(5y)34.7%
ROIC(3y)11.38%
ROIC(5y)18.16%
1.3 Margins
INVA has a better Profit Margin (32.78%) than 96.35% of its industry peers.
In the last couple of years the Profit Margin of INVA has declined.
With an excellent Operating Margin value of 43.21%, INVA belongs to the best of the industry, outperforming 98.44% of the companies in the same industry.
In the last couple of years the Operating Margin of INVA has declined.
With an excellent Gross Margin value of 81.50%, INVA belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 43.21% | ||
| PM (TTM) | 32.78% | ||
| GM | 81.5% |
OM growth 3Y-21.38%
OM growth 5Y-13.2%
PM growth 3Y-54.19%
PM growth 5Y-35.9%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so INVA is still creating some value.
The number of shares outstanding for INVA has been reduced compared to 1 year ago.
Compared to 5 years ago, INVA has less shares outstanding
Compared to 1 year ago, INVA has an improved debt to assets ratio.
2.2 Solvency
INVA has an Altman-Z score of 3.30. This indicates that INVA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of INVA (3.30) is better than 70.83% of its industry peers.
INVA has a debt to FCF ratio of 1.38. This is a very positive value and a sign of high solvency as it would only need 1.38 years to pay back of all of its debts.
INVA has a Debt to FCF ratio of 1.38. This is amongst the best in the industry. INVA outperforms 94.79% of its industry peers.
INVA has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
INVA has a Debt to Equity ratio (0.25) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 1.38 | ||
| Altman-Z | 3.3 |
ROIC/WACC1.18
WACC8.02%
2.3 Liquidity
A Current Ratio of 14.12 indicates that INVA has no problem at all paying its short term obligations.
With an excellent Current ratio value of 14.12, INVA belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
INVA has a Quick Ratio of 13.33. This indicates that INVA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 13.33, INVA belongs to the best of the industry, outperforming 85.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 14.12 | ||
| Quick Ratio | 13.33 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 98.55% over the past year.
Measured over the past years, INVA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -33.21% on average per year.
INVA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.14%.
The Revenue has been growing slightly by 6.57% on average over the past years.
EPS 1Y (TTM)98.55%
EPS 3Y-52.04%
EPS 5Y-33.21%
EPS Q2Q%5300%
Revenue 1Y (TTM)10.14%
Revenue growth 3Y-2.91%
Revenue growth 5Y6.57%
Sales Q2Q%20.44%
3.2 Future
Based on estimates for the next years, INVA will show a very strong growth in Earnings Per Share. The EPS will grow by 83.16% on average per year.
INVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.04% yearly.
EPS Next Y526.32%
EPS Next 2Y240.21%
EPS Next 3Y131.8%
EPS Next 5Y83.16%
Revenue Next Year7.36%
Revenue Next 2Y9.46%
Revenue Next 3Y9.65%
Revenue Next 5Y12.04%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 16.25 indicates a correct valuation of INVA.
Based on the Price/Earnings ratio, INVA is valued cheaper than 84.90% of the companies in the same industry.
INVA is valuated rather cheaply when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.12 indicates a reasonable valuation of INVA.
87.50% of the companies in the same industry are more expensive than INVA, based on the Price/Forward Earnings ratio.
INVA is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.25 | ||
| Fwd PE | 10.12 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INVA indicates a rather cheap valuation: INVA is cheaper than 97.40% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, INVA is valued cheaper than 92.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.5 | ||
| EV/EBITDA | 5.14 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INVA has a very decent profitability rating, which may justify a higher PE ratio.
INVA's earnings are expected to grow with 131.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y240.21%
EPS Next 3Y131.8%
5. Dividend
5.1 Amount
No dividends for INVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:INVA (11/17/2025, 12:30:15 PM)
22.26
+0.01 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners122.15%
Inst Owner Change3.28%
Ins Owners1.05%
Ins Owner Change16.63%
Market Cap1.40B
Revenue(TTM)388.52M
Net Income(TTM)127.34M
Analysts80
Price Target36.92 (65.86%)
Short Float %10.38%
Short Ratio8.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.58%
Min EPS beat(2)50.98%
Max EPS beat(2)130.18%
EPS beat(4)2
Avg EPS beat(4)-50.03%
Min EPS beat(4)-350.17%
Max EPS beat(4)130.18%
EPS beat(8)4
Avg EPS beat(8)-29.12%
EPS beat(12)6
Avg EPS beat(12)-43.13%
EPS beat(16)7
Avg EPS beat(16)-42.57%
Revenue beat(2)2
Avg Revenue beat(2)11.28%
Min Revenue beat(2)6.82%
Max Revenue beat(2)15.75%
Revenue beat(4)4
Avg Revenue beat(4)7.84%
Min Revenue beat(4)3.7%
Max Revenue beat(4)15.75%
Revenue beat(8)8
Avg Revenue beat(8)12.47%
Revenue beat(12)11
Avg Revenue beat(12)11.27%
Revenue beat(16)11
Avg Revenue beat(16)-2.38%
PT rev (1m)-11.71%
PT rev (3m)-10.25%
EPS NQ rev (1m)37.27%
EPS NQ rev (3m)40.47%
EPS NY rev (1m)0%
EPS NY rev (3m)74.13%
Revenue NQ rev (1m)0.33%
Revenue NQ rev (3m)1.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.25 | ||
| Fwd PE | 10.12 | ||
| P/S | 3.61 | ||
| P/FCF | 7.5 | ||
| P/OCF | 6.96 | ||
| P/B | 1.39 | ||
| P/tB | 1.89 | ||
| EV/EBITDA | 5.14 |
EPS(TTM)1.37
EY6.15%
EPS(NY)2.2
Fwd EY9.88%
FCF(TTM)2.97
FCFY13.34%
OCF(TTM)3.2
OCFY14.37%
SpS6.17
BVpS16.03
TBVpS11.8
PEG (NY)0.03
PEG (5Y)N/A
Graham Number22.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.91% | ||
| ROE | 12.61% | ||
| ROCE | 12.16% | ||
| ROIC | 9.43% | ||
| ROICexc | 15.37% | ||
| ROICexgc | 22.41% | ||
| OM | 43.21% | ||
| PM (TTM) | 32.78% | ||
| GM | 81.5% | ||
| FCFM | 48.17% |
ROA(3y)11.21%
ROA(5y)16.95%
ROE(3y)22.61%
ROE(5y)34.7%
ROIC(3y)11.38%
ROIC(5y)18.16%
ROICexc(3y)16.17%
ROICexc(5y)24.46%
ROICexgc(3y)28.95%
ROICexgc(5y)34.96%
ROCE(3y)14.67%
ROCE(5y)23.41%
ROICexgc growth 3Y-8.78%
ROICexgc growth 5Y-15.28%
ROICexc growth 3Y-21.15%
ROICexc growth 5Y-17.48%
OM growth 3Y-21.38%
OM growth 5Y-13.2%
PM growth 3Y-54.19%
PM growth 5Y-35.9%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 1.38 | ||
| Debt/EBITDA | 1.24 | ||
| Cap/Depr | 36.13% | ||
| Cap/Sales | 3.73% | ||
| Interest Coverage | 16.22 | ||
| Cash Conversion | 96.95% | ||
| Profit Quality | 146.98% | ||
| Current Ratio | 14.12 | ||
| Quick Ratio | 13.33 | ||
| Altman-Z | 3.3 |
F-Score6
WACC8.02%
ROIC/WACC1.18
Cap/Depr(3y)4.13%
Cap/Depr(5y)2.48%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.27%
Profit Quality(3y)320.3%
Profit Quality(5y)247.45%
High Growth Momentum
Growth
EPS 1Y (TTM)98.55%
EPS 3Y-52.04%
EPS 5Y-33.21%
EPS Q2Q%5300%
EPS Next Y526.32%
EPS Next 2Y240.21%
EPS Next 3Y131.8%
EPS Next 5Y83.16%
Revenue 1Y (TTM)10.14%
Revenue growth 3Y-2.91%
Revenue growth 5Y6.57%
Sales Q2Q%20.44%
Revenue Next Year7.36%
Revenue Next 2Y9.46%
Revenue Next 3Y9.65%
Revenue Next 5Y12.04%
EBIT growth 1Y4.12%
EBIT growth 3Y-23.66%
EBIT growth 5Y-7.5%
EBIT Next Year-6.31%
EBIT Next 3Y-8.15%
EBIT Next 5YN/A
FCF growth 1Y60.93%
FCF growth 3Y-20.27%
FCF growth 5Y-6.46%
OCF growth 1Y72.8%
OCF growth 3Y-19.65%
OCF growth 5Y-6.03%
INNOVIVA INC / INVA FAQ
Can you provide the ChartMill fundamental rating for INNOVIVA INC?
ChartMill assigns a fundamental rating of 7 / 10 to INVA.
What is the valuation status for INVA stock?
ChartMill assigns a valuation rating of 9 / 10 to INNOVIVA INC (INVA). This can be considered as Undervalued.
How profitable is INNOVIVA INC (INVA) stock?
INNOVIVA INC (INVA) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for INVA stock?
The Price/Earnings (PE) ratio for INNOVIVA INC (INVA) is 16.25 and the Price/Book (PB) ratio is 1.39.
What is the expected EPS growth for INNOVIVA INC (INVA) stock?
The Earnings per Share (EPS) of INNOVIVA INC (INVA) is expected to grow by 526.32% in the next year.